ConductScience.org, home

Paper25015

Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors.

Knaus M and 3 others. Am Heart J, 1978. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors. Papers, record 25015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25015

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors.
PubMed
Journal
Am Heart J
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
3.08
iCite
Revised in PubMed
2019-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knaus MM
2Pfister BB
3Dubach UCU C
4Imhof PRP R

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AgonistsMajor topic
HeartMajor topic
HemodynamicsMajor topic
PropanolaminesMajor topic
Adult
Arrhythmias, Cardiac
Blood Pressure
Clinical Trials as Topic
Dose-Response Relationship, Drug
Electrocardiography
Heart Rate
Humans
Male
Middle Aged
Time Factors

Source PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
6,861,864Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6861864PubMed
6,653,650Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6653650PubMed
6,628,515Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6628515PubMed
6,114,866Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/6114866PubMed
6,113,550The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.Naunyn Schmiedebergs Arch Pharmacol1980https://conductscience.org/library/papers/6113550PubMed
6,108,221Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6108221PubMed
6,108,219Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6108219PubMed
6,102,914Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6102914PubMed
39,584Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.Br Heart J1979https://conductscience.org/library/papers/39584PubMed
33,811Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/33811PubMed
27,371Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/27371PubMed
22,823Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.Naunyn Schmiedebergs Arch Pharmacol1977https://conductscience.org/library/papers/22823PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25015

GET https://conductscience.org/api/papers/v1/25015/authors